Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mei Pharma Inc (MEIP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,812
  • Shares Outstanding, K 36,950
  • Annual Sales, $ 23,250 K
  • Annual Income, $ 2,670 K
  • 36-Month Beta 1.84
  • Price/Sales 3.48
  • Price/Cash Flow 29.28
  • Price/Book 1.86

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.79 +20.67%
on 12/21/17
2.49 -13.25%
on 01/11/18
+0.01 (+0.47%)
since 12/15/17
3-Month
1.79 +20.67%
on 12/21/17
2.90 -25.52%
on 10/26/17
-0.17 (-7.30%)
since 10/17/17
52-Week
1.45 +48.97%
on 02/02/17
3.26 -33.74%
on 07/07/17
+0.62 (+40.26%)
since 01/17/17

Most Recent Stories

More News
MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the...

MEIP : 2.16 (-1.37%)
MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced that a study of voruciclib, an orally available CDK9 inhibitor, was...

MEIP : 2.16 (-1.37%)
MEI Pharma Reports First Quarter Fiscal Year 2018 Results

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its first quarter ended September 30, 2017.

MEIP : 2.16 (-1.37%)
MEI Pharma to Present at Stifel 2017 Healthcare Conference

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., president and chief executive officer,...

MEIP : 2.16 (-1.37%)
Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher

Advanced Accelerator (AAAP) was a big mover last session, as the company saw its shares more than 10% on the day amid huge volumes.

AAAP : 81.84 (+0.02%)
NVS : 86.88 (+0.17%)
MEIP : 2.16 (-1.37%)
Corbus Pharmaceuticals (CRBP) in Focus: Stock Moves 10% Higher

Corbus Pharmaceuticals (CRBP) was a big mover last session, as the company saw its shares rise 10% on the day.

CRBP : 8.20 (+3.80%)
MEIP : 2.16 (-1.37%)
WellCare (WCG) Unit Receives Favorable Star Ratings From CMS

WellCare's (WCG) efforts to boost its Medicare business and provide its Medicare Advantage members quality services have helped it achieve favorable Star Quality ratings from CMS

HUM : 275.75 (+2.07%)
CNC : 111.35 (+1.88%)
WCG : 213.83 (+1.73%)
MEIP : 2.16 (-1.37%)
Aurinia Pharmaceuticals (AUPH) Looks Good: Stock Adds 7.8% in Session

Aurinia Pharmaceuticals saw its shares rise nearly 8% on the day.

AUPH : 5.66 (+5.40%)
MEIP : 2.16 (-1.37%)
Galectin Therapeutics (GALT) in Focus: Stock Moves 6.5% Higher

Galectin Therapeutics, Inc. (GALT) was a big mover last session, as the company saw its shares rise nearly 7% on the day amid huge volumes.

GALT : 5.97 (+11.80%)
MEIP : 2.16 (-1.37%)
Dermira, Inc. (DERM) Soars: Stock Adds 5.3% in Session

Dermira, Inc. (DERM) saw its shares rise over 5% on the day.

DERM : 27.25 (+1.08%)
MEIP : 2.16 (-1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards,...

See More

Key Turning Points

2nd Resistance Point 2.25
1st Resistance Point 2.21
Last Price 2.16
1st Support Level 2.11
2nd Support Level 2.05

See More

52-Week High 3.26
Fibonacci 61.8% 2.57
Fibonacci 50% 2.36
Last Price 2.16
Fibonacci 38.2% 2.14
52-Week Low 1.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.